HSP90 inhibition sensitizes head and neck cancer to platin-based chemoradiotherapy by modulation of the DNA damage response resulting in chromosomal fragmentation
Crossref DOI link: https://doi.org/10.1186/s12885-017-3084-0
Published Online: 2017-01-31
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McLaughlin, Martin
Barker, Holly E.
Khan, Aadil A.
Pedersen, Malin
Dillon, Magnus
Mansfield, David C.
Patel, Radhika
Kyula, Joan N.
Bhide, Shreerang A.
Newbold, Kate L.
Nutting, Christopher M.
Harrington, Kevin J.